Edition:
United States

People: Seattle Genetics Inc (SGEN.OQ)

SGEN.OQ on NASDAQ Stock Exchange Global Select Market

68.76USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$68.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
316,388
52-wk High
$84.35
52-wk Low
$47.79

Liu, Jean 

Ms. Jean I. Liu, J.D. is an Executive Vice President - Legal Affairs, General Counsel, Corporate Secretary of Seattle Genetics, Inc. Ms. Liu has served as our General Counsel, Executive Vice President, Legal Affairs and Corporate Secretary since November 2014. Prior to that, she was with Halozyme Therapeutics, Inc., a publicly traded biotechnology company, from November 2011 to November 2014 where she served as Vice President and General Counsel. From 1998 to 2011, she was with Durect Corporation, a publicly traded biotechnology company, where she served in positions of increasing responsibility, including most recently Chief Legal Officer and Corporate Secretary. Prior to Durect, Ms. Liu was with the law firms of Pillsbury, Madison & Sutro (now Pillsbury Winthrop) and Venture Law Group where she focused on broad areas of legal advisory for early stage companies, including technology transfer, licensing, patents, and copyright and trademark litigation. Ms. Liu received her B.S. in Cellular and Molecular Biology with highest distinction from the University of Michigan, her M.S. in Biology from Stanford University and her J.D. from Columbia University where she was a Harlan Fiske Stone Scholar.

Basic Compensation

Total Annual Compensation, USD 684,963
Restricted Stock Awards, USD 888,290
Long-Term Incentive Plans, USD --
All Other, USD 826,690
Fiscal Year Total, USD 2,399,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Clay Siegall

8,616,340

Todd Simpson

3,061,800

Jean Liu

2,399,940

Darren Cline

--

Vaughn Himes

2,760,340

Felix Baker

575,165
As Of  30 Dec 2017